Publications by authors named "Menghao Dong"

Claim this Profile
T
The Predictive Value of NLR, PLR, LMR, NPAR and D-Dimer on the Efficacy and Prognosis of First-Line Immunotherapy for Extensive-Stage Small Cell Lung Cancer.
Yuanyuan Shen, Jinnan Wang, Qingling Hua, Menghao Dong

J Inflamm Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling breast cancer response to neoadjuvant chemotherapy through integrated genomic, transcriptomic, and circulating tumor DNA analysis.
Menghao Dong, Jian Chen, Nannan Lu, Song Wang, Wenhui Wei

Breast Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of pegylated liposomal doxorubicin and epirubicin as neoadjuvant chemotherapy for breast cancer.
Yuanyuan Shen, Qingling Hua, Menghao Dong, Wei Jin, Xueyang Hu

Front Cell Dev Biol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid PTEN loss affects the therapeutic response by promoting stress granule assembly and impairing phagocytosis by macrophages in breast cancer.
Yan Li, Chao Xu, Xiaojun Qian, Gang Wang, Chaoqiang Han, Menghao Dong

Cell Death Discov· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNMT1-mediated demethylation of lncRNA MEG3 promoter suppressed breast cancer progression by repressing Notch1 signaling pathway.
Tingting Pan, Haiwen Ding, Le Jin, Shaobo Zhang, Delin Wu, Menghao Dong

Cell Cycle· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DFT Study on the Effect of Na on NO Reduction with Nitrogen-Containing Char from Zhundong Coal.
Menghao Dong, Hongfang Wang, Lianfei Xu, Yile Zou, Boxiong Shen

J Phys Chem A· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline Mutations and Up-Regulation of PI3K-AKT Pathway Serve as Potential Indicators of Lack of Response to Neoadjuvant Chemotherapy in Stage II/III Breast Cancer.
Menghao Dong, Benjie Shan, Xinghua Han, Xiaotian Zhao, Fufeng Wang

Front Oncol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-26a inhibits cell proliferation and invasion by targeting FAM98A in breast cancer.
Tan Liu, Ziming Wang, Menghao Dong, Jingjing Wei, Yueyin Pan

Oncol Lett· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standard-dose epirubicin increases the pathological complete response rate in neoadjuvant chemotherapy for breast cancer: a multicenter retrospective study.
Ben-Jie Shan, Xia-Bo Shen, Wei Jin, Meng-Hao Dong, Xing-Hua Han

Gland Surg· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity.
Yi Huang, Huanyu Wang, Yize Hao, Hualong Lin, Menghao Dong

Nat Cell Biol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis